Morgan Stanley
ICCC icon

Morgan Stanley’s ImmuCell ICCC Stock Holding History

Morgan Stanley’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Buy
221,716
+97,000
+78% +$621K ﹤0.01% 4968
2025
Q4 		$767K Buy
124,716
+19,600
+19% +$115K ﹤0.01% 5311
2025
Q3 		$657K Buy
105,116
+200
+0.2% +$1.26K ﹤0.01% 5386
2025
Q2 		$730K Buy
104,916
+28,000
+36% +$163K ﹤0.01% 5268
2025
Q1 		$368K Buy
76,916
+13,800
+22% +$70.8K ﹤0.01% 5468
2024
Q4 		$325K Sell
63,116
-400
-0.6% -$1.59K ﹤0.01% 5593
2024
Q3 		$231K Sell
63,516
-3,300
-5% -$12.8K ﹤0.01% 5702
2024
Q2 		$324K Buy
66,816
+2,100
+3% +$10.1K ﹤0.01% 5479
2024
Q1 		$343K Sell
64,716
-104,432
-62% -$538K ﹤0.01% 5491
2023
Q4 		$861K Buy
169,148
+81,274
+92% +$397K ﹤0.01% 5370
2023
Q3 		$469K Buy
87,874
+12,900
+17% +$65.5K ﹤0.01% 5195
2023
Q2 		$375K Buy
74,974
+3,600
+5% +$18.4K ﹤0.01% 5362
2023
Q1 		$365K Sell
71,374
-5,500
-7% -$35.7K ﹤0.01% 5433
2022
Q4 		$469K Buy
76,874
+2,800
+4% +$20.2K ﹤0.01% 5278
2022
Q3 		$554K Buy
74,074
+7,300
+11% +$59.6K ﹤0.01% 5222
2022
Q2 		$580K Hold
66,774
– – ﹤0.01% 5342
2022
Q1 		$644K Buy
66,774
+10,300
+18% +$88.9K ﹤0.01% 5257
2021
Q4 		$452K Buy
56,474
+3,599
+7% +$32.2K ﹤0.01% 5610
2021
Q3 		$495K Sell
52,875
-2,999
-5% -$28.4K ﹤0.01% 5504
2021
Q2 		$531K Buy
55,874
+800
+1% +$7.8K ﹤0.01% 5485
2021
Q1 		$531K Sell
55,074
-2,500
-4% -$23.4K ﹤0.01% 5119
2020
Q4 		$343K Hold
57,574
– – ﹤0.01% 5291
2020
Q3 		$313K Sell
57,574
-1,492
-3% -$8.27K ﹤0.01% 4883
2020
Q2 		$279K Sell
59,066
-10
-0% -$44 ﹤0.01% 4912
2020
Q1 		$224K Buy
59,076
+637
+1% +$3.14K ﹤0.01% 4814
2019
Q4 		$301K Buy
58,439
+43,371
+288% +$224K ﹤0.01% 5214
2019
Q3 		$84K Buy
15,068
+1,841
+14% +$10.8K ﹤0.01% 5505
2019
Q2 		$86K Sell
13,227
-700
-5% -$4.44K ﹤0.01% 5395
2019
Q1 		$88K Buy
13,927
+1,195
+9% +$8.53K ﹤0.01% 5444
2018
Q4 		$90K Buy
12,732
+1,000
+9% +$7.73K ﹤0.01% 5589
2018
Q3 		$98K Buy
11,732
+500
+4% +$3.6K ﹤0.01% 5694
2018
Q2 		$77K Sell
11,232
-1,500
-12% -$10.8K ﹤0.01% 5804
2018
Q1 		$89K Sell
12,732
-300
-2% -$2.2K ﹤0.01% 5737
2017
Q4 		$115K Sell
13,032
-6,408
-33% -$52.4K ﹤0.01% 5599
2017
Q3 		$126K Buy
19,440
+12,100
+165% +$79.2K ﹤0.01% 5510
2017
Q2 		$54K Hold
7,340
– – ﹤0.01% 5833
2017
Q1 		$41K Hold
7,340
– – ﹤0.01% 5892
2016
Q4 		$44K Sell
7,340
-10,305
-58% -$62.7K ﹤0.01% 5783
2016
Q3 		$136K Sell
17,645
-7,410
-30% -$53.9K ﹤0.01% 5183
2016
Q2 		$173K Sell
25,055
-10,506
-30% -$70.9K ﹤0.01% 5008
2016
Q1 		$244K Buy
35,561
+13,716
+63% +$91.4K ﹤0.01% 4861
2015
Q4 		$162K Buy
21,845
+16,845
+337% +$119K ﹤0.01% 5185
2015
Q3 		$30K Buy
5,000
+4,994
+83,233% +$40.7K ﹤0.01% 5911
2015
Q2 		$0 Buy
6
+1
+20% +$7 ﹤0.01% 6687
2015
Q1 		$0 Sell
5
-5,103
-100% -$32.2K ﹤0.01% 6591
2014
Q4 		$25K Sell
5,108
-108
-2% -$515 ﹤0.01% 5996
2014
Q3 		$26K Sell
5,216
-12,400
-70% -$58K ﹤0.01% 5925
2014
Q2 		$77K Sell
17,616
-8,723
-33% -$36.7K ﹤0.01% 5609
2014
Q1 		$126K Sell
26,339
-495
-2% -$2.15K ﹤0.01% 5344
2013
Q4 		$114K Sell
26,834
-3,252
-11% -$14.1K ﹤0.01% 5306
2013
Q3 		$142K Buy
30,086
+458
+2% +$1.79K ﹤0.01% 5002
2013
Q2 		$111K Buy
+29,628
New +$106K ﹤0.01% 5047

Other funds holding ICCC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley's ICCC Position: Q1 2026 in Review

Morgan Stanley increased its ImmuCell (ICCC) stake by 78% in Q1 2026, buying an estimated $621K and bringing the position to 221,716 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #4968.

Morgan Stanley first reported a position in ICCC in Q2 2013 and has held it in 52 quarters since. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.

  • Morgan Stanley held 221,716 shares of ImmuCell worth $1.4M as of Q1 2026.
  • Morgan Stanley bought 97,000 ImmuCell shares in Q1 2026, an estimated $621K.
  • ImmuCell made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4968 holding.
  • Morgan Stanley first reported a position in ImmuCell in Q2 2013 and has held it in 52 quarters since.
  • 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.